Login
Get Started
Today
Browse
Screens
Folios
Discuss
Learn
Browse
Shares
Healthcare
Pharmaceuticals
Luye Pharma
2186 -
Luye Pharma
Share News
HK$5.47
0.2 4.4%
Last Trade -
8:08am
Sector
Healthcare
RiskRating
Speculative
Size
Mid Cap
Style
Style Neutral
Market Cap
£1.60bn
Enterprise Value
£2.04bn
Revenue
£678.0m
Position in Universe
655th / 6135
Quality
Value
Momentum
Stock
Rank™
StockReport™
Tools
Compare with...
Run through checklist
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
Charts
News
Discussions
2186 Dividends
All News
All News
Reuters News
Company Announcements
BRIEF-Luye Pharma Group Says Clinical Trial Application Of LY01015 Has Been Formally Accepted By CDE Of NMPA
Thu 2:43pm
News
BRIEF-Luye Pharma Says Unit Entered Into An Exclusive Agreement
18th Feb
News
BRIEF-Luye Pharma Group To Issue Certain New Shares Of Co To A Potential Investor
29th Jan
News
BRIEF-Luye Pharma Says Group Of Investors Agreed To Invest RMB194.8 Mln In Shandong Boan
25th Jan
News
BRIEF-Luye Pharma Says NMPA Approved Marketing Registration Of Risperidone Microspheres For Injection
14th Jan
News
BRIEF-Luye Pharma Group Announces Third Parties' Investments In Shandong Boan Biological Technology
4th Jan
News
BRIEF-Luye Pharma Group Says Injection Ly03009 Commenced Phase I Clinical Trial In Australia
4th Jan
News
BRIEF-Luye Pharma Announces Inclusion Of Lipusu In New Catalogue Of National Reimbursement Drug List
28th Dec '20
News
BRIEF-Luye Pharma Announces Investment In Shandong Boan Biological Technology
28th Dec '20
News
BRIEF-Pharma Mar And Luye Pharma Have Started Phase I Clinical Trial With Lurbinectedin In China
1st Dec '20
News
BRIEF-Luye Pharma Group Gets Approval Of Initiating Clinical Trial With Denosumab Biosimilar Candidate (Ly06006/Ly01011) In Europe
23rd Oct '20
News
BRIEF-Luye Pharma Gets Clinical Trial Approval For Rivastigmine Multi-Day Transdermal Patch In China
1st Sep '20
News
BRIEF-Luye Pharma Group Says HY Profit Attributable RMB 539.4 Mln
27th Aug '20
News
BRIEF-Luye Pharma Group Announces Approval For Clinical Trial For LPM4870108 Tablets In China
27th Aug '20
News
BRIEF-Luye Pharma Group Gets Approval For Clinical Trial For Lurbinectedin (Ly01017) In China
26th Aug '20
News
BRIEF-Pharma Mar's Lurbinectedin Receives Acceptance For Clinical Trial Application In China
29th Jun '20
News
BRIEF-Luye Pharma Group Says Clinical Trial Application Of Lurbinected Accepted By CDE Of PRC
29th Jun '20
News
BRIEF-Luye Pharma Group Gets Acceptance For Clinical Trial Application Of LPM4870108 Tablets
23rd Jun '20
News
BRIEF-Luye Pharma Group Says IND Application Of LY03013 Accepted By CDE In China
18th Jun '20
News
BRIEF-Luye Pharma Group Says Clinical Trial Application Of Injection Accepted
11th Jun '20
News
1
2
3
4
5
6
7
Next »
Unlock the metrics for all these stocks and more...
Unlock
with Google
Unlock with Facebook
Unlock with Email
Unlock
with Google
Unlock
with Facebook
or
Unlock with your email
© Stockopedia 2021, Refinitiv, Share Data Services.
Facebook
Twitter
Youtube
Instagram
RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our
Terms of Use
,
Privacy
and
Disclaimer
policies.
Unlock the metrics for all these stocks and more...
Unlock
with Google
Unlock with Facebook
Unlock with Email
Unlock
with Google
Unlock
with Facebook
or
Unlock with your email